Ruurd Torensma

12.6k total citations · 3 hit papers
135 papers, 10.1k citations indexed

About

Ruurd Torensma is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ruurd Torensma has authored 135 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Immunology, 39 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Ruurd Torensma's work include Immunotherapy and Immune Responses (50 papers), Immune Cell Function and Interaction (22 papers) and T-cell and B-cell Immunology (22 papers). Ruurd Torensma is often cited by papers focused on Immunotherapy and Immune Responses (50 papers), Immune Cell Function and Interaction (22 papers) and T-cell and B-cell Immunology (22 papers). Ruurd Torensma collaborates with scholars based in Netherlands, United States and Germany. Ruurd Torensma's co-authors include Carl G. Figdor, Yvette van Kooyk, Sandra J. van Vliet, Gerard C.F. van Duijnhoven, Teunis B. H. Geijtenbeek, Gosse J. Adema, I. Jolanda M. de Vries, Paul J. Tacken, Vineet N. KewalRamani and Jeena Middel and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Blood.

In The Last Decade

Ruurd Torensma

135 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells

2000 1.9k citations Teunis B. H. Geijtenbeek, Ruurd Torensma et al. Cell profile →
Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses

2000 1.4k citations Teunis B. H. Geijtenbeek, Ruurd Torensma et al. Cell profile →
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

2007 615 citations Paul J. Tacken, I. Jolanda M. de Vries et al. profile →

Peers

Countries citing papers authored by Ruurd Torensma

Since Specialization

Citations

This map shows the geographic impact of Ruurd Torensma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruurd Torensma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruurd Torensma more than expected).

Fields of papers citing papers by Ruurd Torensma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruurd Torensma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruurd Torensma. The network helps show where Ruurd Torensma may publish in the future.

Co-authorship network of co-authors of Ruurd Torensma

This figure shows the co-authorship network connecting the top 25 collaborators of Ruurd Torensma. A scholar is included among the top collaborators of Ruurd Torensma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruurd Torensma. Ruurd Torensma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines 2016 ·Cancer Research ·Ghaith Bakdash, Sonja I. Buschow, Mark A.J. Gorris, Altuna Halilović, Stanleyson V. Hato, Annette E. Sköld, Gerty Schreibelt, Simone P. Sittig, Ruurd Torensma, Tjitske Duiveman‐de Boer, Christoph Schröder, Evelien Smits, Carl G. Figdor, I. Jolanda M. de Vries	90
2	Cord Blood Mesenchymal Stem Cells Suppress DC-T Cell Proliferation via Prostaglandin B2 2014 ·Stem Cells and Development ·Lieke C. J. van den Berk, Bas Jansen, Stuart G. Snowden, (unknown), Christian Gilissen, Gesine Kögler, Carl G. Figdor, Craig E. Wheelock, Ruurd Torensma	14
3	The Impact of Cell Source, Culture Methodology, Culture Location, and Individual Donors on Gene Expression Profiles of Bone Marrow-Derived and Adipose-Derived Stromal Cells 2012 ·Stem Cells and Development ·Ruurd Torensma, Henk‐Jan Prins, Ellen Schrama, Eugène T.P. Verwiel, Anton C. Martens, Helene Roelofs, Bas Jansen	39
4	Cancer Patients Treated with Sunitinib or Sorafenib Have Sufficient Antibody and Cellular Immune Responses to Warrant Influenza Vaccination 2011 ·Clinical Cancer Research ·Sasja F. Mulder, Joannes F.M. Jacobs, (unknown), Joep M.D. Galama, Ingrid M.E. Desar, Ruurd Torensma, Steven Teerenstra, Peter F.A. Mulders, Kris Vissers, Cornelis J.A. Punt, I. Jolanda M. de Vries, Carla M.L. van Herpen	27
5	Preferential recruitment of bone marrow-derived cells to rat palatal wounds but not to skin wounds 2011 ·Archives of Oral Biology ·(unknown), (unknown), Christos Katsaros, Ruurd Torensma, Johannes W. Von den Hoff	7
6	Hematopoietic Stem Cells Are Coordinated by the Molecular Cues of the Endosteal Niche 2010 ·Stem Cells and Development ·Menno ter Huurne, Carl G. Figdor, Ruurd Torensma	12
7	IL-4 and IL-13 Alter Plasmacytoid Dendritic Cell Responsiveness to CpG DNA and Herpes Simplex Virus-1 2010 ·Journal of Investigative Dermatology ·Jurjen Tel, Ruurd Torensma, Carl G. Figdor, I. Jolanda M. de Vries	17
8	Functional Differences Between Mesenchymal Stem Cell Populations Are Reflected by Their Transcriptome 2009 ·Stem Cells and Development ·Bas Jansen, Christian Gilissen, Helene Roelofs, Aneta Oziemlak, Joris A. Veltman, Reinier Raymakers, Joop H. Jansen, Gesine Kögler, Carl G. Figdor, Ruurd Torensma, Gosse J. Adema	114
9	Monocyte Cell Surface Glycosaminoglycans Positively Modulate IL-4-Induced Differentiation toward Dendritic Cells 2008 ·The Journal of Immunology ·Els den Dekker, Sander Grefte, (unknown), Gerdy B. ten Dam, Elly M. M. Versteeg, Lieke C. J. van den Berk, Bellinda A. Bladergroen, Toin H. Van Kuppevelt, Carl G. Figdor, Ruurd Torensma	38
10	No Advantage of Cell-Penetrating Peptides over Receptor-Specific Antibodies in Targeting Antigen to Human Dendritic Cells for Cross-Presentation 2008 ·The Journal of Immunology ·Paul J. Tacken, Ben Joosten, Anita Reddy, Dayang Wu, Annemarie Eek, Peter Laverman, Anke Kretz-Rommel, Gosse J. Adema, Ruurd Torensma, Carl G. Figdor	34
11	In Vivo Recruitment of Hematopoietic Cells Using Stromal Cell–Derived Factor 1 Alpha–Loaded Heparinized Three-Dimensional Collagen Scaffolds 2008 ·Tissue Engineering Part A ·Bellinda A. Bladergroen, (unknown), (unknown), Toin H. Van Kuppevelt, A.A. Poot, Jan Feijén, Carl G. Figdor, Ruurd Torensma	33
12	Skeletal Muscle Development and Regeneration 2007 ·Stem Cells and Development ·Sander Grefte, Anne Marie Kuijpers‐Jagtman, Ruurd Torensma, Johannes W. Von den Hoff	130
13	Internalizing Antibodies to the C-Type Lectins, L-SIGN and DC-SIGN, Inhibit Viral Glycoprotein Binding and Deliver Antigen to Human Dendritic Cells for the Induction of T Cell Responses 2006 ·The Journal of Immunology ·Naveen Dakappagari, Toshiaki Maruyama, Mark W. Renshaw, Paul J. Tacken, Carl G. Figdor, Ruurd Torensma, Martha A. Wild, Dayang Wu, Katherine S. Bowdish, Anke Kretz-Rommel	39
14	Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody 2005 ·Blood ·Paul J. Tacken, I. Jolanda M. de Vries, Karlijn Gijzen, Ben Joosten, Dayang Wu, Russell P. Rother, Susan J. Faas, Cornelis J.A. Punt, Ruurd Torensma, Gosse J. Adema, Carl G. Figdor	219
15	Ceramic hydroxyapatite coating on titanium implants drives selective bone marrow stromal cell adhesion 2003 ·Clinical Oral Implants Research ·Ruurd Torensma, Petra J. ter Brugge, John A. Jansen, Carl G. Figdor	15
16	Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses breakdown → 2000 ·Cell ·Teunis B. H. Geijtenbeek, Ruurd Torensma, Sandra J. van Vliet, Gerard C.F. van Duijnhoven, Gosse J. Adema, Yvette van Kooyk, Carl G. Figdor	1375
17	Toxins A and B ofClostridium difficile 1994 ·FEMS Microbiology Reviews ·M. J. H. M. Wolfhagen, Ruurd Torensma, Ad C. Fluit, J. Verhoef	6
18	Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children. 1994 ·Gut ·M. J. H. M. Wolfhagen, (unknown), Ad C. Fluit, Ruurd Torensma, (unknown), A. Fleer, J. Verhoef	17
19	THE ROOT EFFECT OF BUCCINUM-UNDATUM HEMOCYANIN - ANALYSIS OF THE OXYGEN BINDING 1984 ·University of Groningen research database (University of Groningen / Centre for Information Technology) ·Ruurd Torensma, (unknown), Ole Brix, Alfredo Colosimo, Maurizio Brunori	2
20	OXYGEN BINDING OF NEPTUNEA-ANTIQUA HEMOCYANIN - THE SIGNIFICANCE OF ALLOSTERIC LIGANDS 1981 ·University of Groningen research database (University of Groningen / Centre for Information Technology) ·Ruurd Torensma, Ole Brix	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact